Related Experiment Video
Updated: Mar 28, 2026
06:18
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
15.0K
Laboratory Evaluation of a Dual-Path Platform Assay for Rapid Point-of-Care HIV and Syphilis Testing
S R Leon1, L B Ramos2, S K Vargas2
1Laboratory of Sexual Health, Universidad Peruana Cayetano Heredia, Lima, Peru Dirección de Investigación, Socios en Salud Sucursal del Perú, Lima, Peru srleons@gmail.com.
Journal of Clinical Microbiology
|December 15, 2015
Summary
The Chembio HIV-syphilis rapid test shows high accuracy for detecting HIV and syphilis antibodies. Its electronic reader provides reliable results, aiding in disease diagnosis.
Area of Science:
- Infectious Diseases
- Immunology
- Medical Diagnostics
Background:
- Accurate and rapid detection of HIV and syphilis is crucial for effective public health management.
- Point-of-care diagnostics are essential for timely diagnosis and treatment initiation.
Purpose of the Study:
- To evaluate the laboratory performance of the Chembio dual-path platform HIV-syphilis rapid immunodiagnostic test.
- To assess the accuracy of both visual and electronic reader interpretation for HIV and Treponema pallidum antibody detection.
Main Methods:
- Laboratory assessment of a rapid immunodiagnostic test using 450 characterized serum specimens.
- Comparison of visual interpretation versus electronic reader performance for HIV and syphilis antibody detection.
Main Results:
- HIV antibody detection demonstrated 100% sensitivity and 98.7% specificity (visual/electronic).
- Syphilis antibody detection showed 94.7% sensitivity and 100.0% specificity (visual).
- Electronic reader syphilis detection yielded 94.7% sensitivity and 99.7% specificity.
Conclusions:
- The Chembio dual-path platform demonstrates high performance for detecting HIV and syphilis antibodies.
- The electronic reader offers a reliable method for interpreting results, supporting diagnostic accuracy.
